Literature DB >> 1134537

Letter: Cancer treatment needs better antiemetics.

V M Whitehead.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 1134537     DOI： 10.1056/NEJM197507242930416

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Myths and realities of antiemetic treatment.

Authors:  M Martin
Journal:  Br J Cancer Suppl       Date:  1992-12

Review 2.  Adverse effects of cancer chemotherapy. An overview of techniques for avoidance/minimisation.

Authors:  M Nicolson; R C Leonard
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

Review 3.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

4.  Effectiveness of multiple muscle-site EMG biofeedback and relaxation training in reducing the aversiveness of cancer chemotherapy.

Authors:  T G Burish; C D Shartner; J N Lyles
Journal:  Biofeedback Self Regul       Date:  1981-12

5.  Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.

Authors:  M McCabe; F P Smith; J S Macdonald; P V Woolley; D Goldberg; P S Schein
Journal:  Invest New Drugs       Date:  1988-09       Impact factor: 3.850

6.  Metoclopramide in the reduction of nausea and vomiting associated with combined chemotherapy.

Authors:  R Cox; C E Newman; M J Leyland
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity. III. Ultrastructural characterization of bile duct injury.

Authors:  N W Kretschmer; P J Boor; R A el Azhary; A E Ahmed; E S Reynolds
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  Oral levonantradol in the control of cancer chemotherapy-induced emesis.

Authors:  J Welsh; F Stuart; G Sangster; R Milstead; S Kaye; H Cash; D Charlton; K Calman
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 9.  [Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].

Authors:  A Du Bois
Journal:  Med Klin (Munich)       Date:  1998-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.